|
|
H. Lundbeck A/S - Company Profile Snapshot
| Company Profile: |
H. Lundbeck A/S |
| Ticker: |
LUN |
| Exchanges: |
CPH |
| 2007 Sales: |
10,985,000,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
DENMARK |
| Employees: |
5097 |
Business Description
H. Lundbeck A/S. The Group's principal activities are the research, development, production, marketing and sale of pharmaceuticals for treating diseases of the central nervous system (CNS). The Group specialises in psychiatry and neurology, focusing exclusively on treatments of psychosis, depression, anxiety, schizophrenia, Parkinson's disease, Alzheimer's disease and dementia. The product group includes Cipralex, Lexapro, Azilect and other pharmaceuticals. The Group operates globally in 54 countries.
|
Not the Report you are looking for? Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
